Adults with chronic spontaneous urticaria experienced greater mortality, probably due to increased risks for comorbidities, ...

Approximately 45,000 patients have begun using omalizumab for food allergy in the year since its approval by the FDA, Ahmar Iqbal, MD, therapeutic area lead for respiratory and influenza at Genentech, ...

As market analysts highlight XRP Ledger's enormous untapped potential, ExoraPad is strategically placed to bridge this gap by ...